MedReleaf Australia Revenue and Competitors

Setting The Medical Grade Standard for Medical Cannabis, MedReleaf Australia is federally licensed to cultivate and manufacture medical cannabis, as well as to import, export and wholesale products by the Queensland Government and Federal Government’s Office of Drug Control (ODC). Our Australian privately owned company is backed by more than 50 years of pharmaceutical and healthcare expertise and is driven by Research and Development. We dedicate ourselves to innovation and operational excellence and stakeholder satisfaction. We are an asset light and efficient company providing products and services to GPs and pharmacists across Australia and New Zealand, with an exclusive partnership with Aurora Cannabis, Canada (ACB|TSX)\n\nMedReleaf Australia supplies a range of EuGMP products as well as our own locally manufactured range distributed to the Australian medical market. Products that are carefully cultivated in state-of-the-art EuGMP, ISO 9001 certified facilities in Canada and Australia. \n\nMedReleaf Australia is proud of its innovative MedReleaf Concession Scheme which is changing the quality of lives of disadvantaged Australians every day.